Using intravital imaging we showed that short-term transient inhibition of FAK can deprive pancreatic cancer cells of their supportive fibrotic niche and render them exquisitely vulnerable to subsequent chemotherapy, whilst minimising the likelihood of resistance and toxicity occurring due to long-term chronic treatment. Here, PTK2 is linked to familial pancreatic carcinoma.